Post-earnings recap
Reported
Tue, Feb 8, 2022
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Despite missing on EPS expectations, Haemonetics' stock rose by 16.16% following the earnings report. This increase may reflect investor optimism or a positive market reaction to other factors not detailed in the earnings call. The lack of guidance and management commentary leaves some uncertainty about future performance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.45 | N/A | -39.84% |
No transcript is on record, and the analysis is based on numerical results only.